Senzime AB (publ)

Senzime AB (publ)

SNZZF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$36.98M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Senzime AB (publ)Senzime AB (publ)-5.7--38%-0.1

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$36.98 Million
Enterprise Value$29.21 Million
Earnings per Share$-0.93
Beta0.4
Outstanding Shares157,215,046

Return

Return on Equity-38.50%ROE
Return on Assets-31.02%
Return on Invested Capital-32.54%

Valuation & Multiples

P/E Ratio-5.65P/E Ratio
PEG10.28PEG
Price to Sales-Price to Sales
Price to Book Ratio0.24Price to Book Ratio
Enterprise Value to Revenue0.27
Enterprise Value to EBIT-0.31
Enterprise Value to Net Income-1
Total Debt to Enterprise0.72
Debt to Equity0.08Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
October 29, 2026
EPS
-$0.01
Reported
Revenue
$2.99 M
Est. $3.00 M

Next Earnings Call

Expected Date
January 28, 2027
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
$3.62 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Senzime AB (publ)

59 employees
CEO: Philip Siberg

Senzime AB (publ) is a medical technology firm specializing in the creation and distribution of advanced patient monitoring solutions. These systems are designed to oversee patients undergoing anesthesia across various global markets, in...